Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53

FEBS Letters

Volumn 585, Issue 1, 2011, Pages 29-35

  Rho, Seung Bae ^a   Lee, Jeong Heon ^b   Park, Mi Sun ^a   Byun, Hyun Jung ^a   Kang, Sokbom ^a   Seo, Sang Soo ^a   Kim, Joo Young ^a   Park, Sang Yoon ^a  

^a National Cancer Center   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Apoptosis; Lung carcinoma cell; p53; TCTP; Yeast two hybrid

Indexed keywords

POLYPEPTIDE; PROTEIN P53; SMALL INTERFERING RNA; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; RNA INTERFERENCE; TWO HYBRID SYSTEM; YEAST;

AMINO ACID SEQUENCE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STABILITY; RNA INTERFERENCE; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 78650873411     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.11.014     Document Type: Article

References (25)

1. F. Li, D. Zhang, and K. Fujise Characterization of fortilin, a novel anti-apoptotic protein J. Biol. Chem. 276 2001 47542 47549
2. P. Thaw, N.J. Baxter, A.M. Hounslow, C. Price, J.P. Waltho, and C.J. Craven Structure of TCTP reveals unexpected relationship with guanine nucleotide-free chaperones Nat. Struct. Biol. 8 2001 701 704
3. U.A. Bommer, and B.J. Thiele The translationally controlled tumour protein (TCTP) Int. J. Biochem. Cell Biol. 36 2004 379 385
4. M. Tuynder, L. Susini, S. Prieur, S. Besse, G. Fiucci, R. Amson, and A. Telerman Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1 Proc. Natl. Acad. Sci. USA 99 2002 14976 14981
5. F.R. Yarm PIk phosphorylation regulates the microtubule-stabilizing protein TCTP Mol. Cell. Biol. 22 2002 6209 6221
6. S.M. MacDonald, T. Rafnar, J. Langdon, and L.M. Lichtenstein Molecular identification of an IgE-dependent histamine-releasing factor Science 269 1995 688 690
7. J.M. Langdon, B.M. Vonakis, and S.M. MacDonald Identification of the interaction between the human recombinant histamine releasing factor/translationally controlled tumor protein and elongation factor-1 delta (also known as eElongation factor-1B beta) Biochim. Biophys. Acta 1688 2004 232 236
8. N. Amzallag, B.J. Passer, D. Allanic, E. Segura, C. Thery, B. Goud, R. Amson, and A. Telerman TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway J. Biol. Chem. 279 2004 46104 46112
9. J. Jung, M. Kim, M.J. Kim, J. Kim, J. Moon, J.S. Lim, M. Kim, and K. Lee Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na, K-ATPase alpha subunit and inhibits the pump activity in HeLa cells J. Biol. Chem. 279 2004 49868 49875
10. Y. Yang, F. Yang, Z. Xiong, Y. Yan, X. Wang, M. Nishino, D. Mirkovic, J. Nguyen, H. Wang, and X.F. Yang An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity Oncogene 24 2005 4778 4788
11. H. Liu, H.W. Peng, Y.S. Cheng, H.S. Yuan, and H.F. Yang-Yen Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP Mol. Cell. Biol. 25 2005 3117 3126
12. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat. Rev. Cancer 2 2002 594 604
13. C.J. Sherr, and J.D. Weber The ARF/p53 pathway Curr. Opin. Genet. Dev. 10 2000 94 99
14. J.D. Weber, L.J. Taylor, M.F. Roussel, C.J. Sherr, and D. Bar-Sagi Nucleolar Arf sequesters Mdm2 and activates p53 Nat. Cell Biol. 1 1999 20 26
15. D.P. Lane P53 and human cancers Br. Med. Bull. 50 1994 582 599
16. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
17. M. Ashcroft, and K.H. Vousden Regulation of p53 stability Oncogene 18 1999 7637 7643
18. S.N. Jones, A.E. Roe, L.A. Donehower, and A. Bradley Rescue to embryonic lethality in Mdm2-deficient mice by absence of p53 Nature 378 1995 206 208
19. R. Montes de Oca Luna, D.S. Wagner, and G. Lozano Rescue of early embryonic lethality in Mdm2-deficient mice by deletion of p53 Nature 378 1995 203 206
20. S.B. Rho, K.H. Lee, J.W. Kim, K. Shiba, Y.J. Jo, and S. Kim Interaction between human tRNA synthetases involves repeated sequence elements Proc. Natl. Acad. Sci. USA 93 1996 10128 10133
21. H. Bohm, R. Benndorf, M. Gaestel, B. Gross, P. Nurnberg, R. Kraft, A. Otto, and H. Bielka The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning and primary structure Biochem. Int. 19 1989 277 286
22. R. Yenofsky, S. Cereghini, A. Krowczynska, and G. Brawerman Regulation of mRNA utilization in mouse erythroleukemia cells induced to differentiate by exposure to dimethyl sulfoxide Mol. Cell. Biol. 3 1983 1197 1203
23. S.H. Chen, P.-S. Wu, C.-H. Chou, Y.-T. Yan, H. Liu, S.-Y. Weng, and H.-F. Yang-Yen A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner Mol. Biol. Cell 18 2007 2525 2532
24. A. Ito, Y. Kawaguchi, C.-H. Lai, J.J. Kovacs, Y. Higashimoto, E. Appella, and T.-P. Yao MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation EMBO J. 21 2002 6236 6245
25. C. Prives Signaling to p53: breaking the MDM2-p53 circuit Cell 95 1998 5 8